Stoke Therapeutics Stock Price History

STOK Stock  USD 8.33  0.07  0.85%   
Below is the normalized historical share price chart for Stoke Therapeutics extending back to June 19, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Stoke Therapeutics stands at 8.33, as last reported on the 20th of March, with the highest price reaching 8.41 and the lowest price hitting 8.00 during the day.
IPO Date
19th of June 2019
200 Day MA
12.4643
50 Day MA
9.5086
Beta
0.985
 
Covid
If you're considering investing in Stoke Stock, it is important to understand the factors that can impact its price. Stoke Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0938, which indicates the firm had a -0.0938 % return per unit of risk over the last 3 months. Stoke Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Stoke Therapeutics' Risk Adjusted Performance of (0.1), coefficient of variation of (827.00), and Variance of 22.25 to confirm the risk estimate we provide.
  
The value of Total Stockholder Equity is estimated to slide to about 193.3 M. The value of Common Stock Total Equity is estimated to slide to 2,750. At this time, Stoke Therapeutics' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 2.73 this year, although the value of Price To Operating Cash Flows Ratio will most likely fall to (7.20). Stoke Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0938

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSTOK

Estimated Market Risk

 4.77
  actual daily
42
58% of assets are more volatile

Expected Return

 -0.45
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Stoke Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stoke Therapeutics by adding Stoke Therapeutics to a well-diversified portfolio.
Price Book
1.9504
Enterprise Value Ebitda
(3.62)
Price Sales
12.8523
Shares Float
36.8 M
Wall Street Target Price
23.875

Stoke Therapeutics Stock Price History Chart

There are several ways to analyze Stoke Stock price data. The simplest method is using a basic Stoke candlestick price chart, which shows Stoke Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 6, 202512.74
Lowest PriceMarch 3, 20257.4

Stoke Therapeutics March 20, 2025 Stock Price Synopsis

Various analyses of Stoke Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Stoke Stock. It can be used to describe the percentage change in the price of Stoke Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Stoke Stock.
Stoke Therapeutics Accumulation Distribution 52,193 
Stoke Therapeutics Price Daily Balance Of Power 0.17 
Stoke Therapeutics Price Rate Of Daily Change 1.01 
Stoke Therapeutics Price Action Indicator 0.16 

Stoke Therapeutics March 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Stoke Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Stoke Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Stoke Stock and then apply it to test your longer-term investment strategies against Stoke.

Stoke Stock Price History Data

The price series of Stoke Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 5.58 with a coefficient of variation of 15.21. The price distribution for the period has arithmetic mean of 10.02. The median price for the last 90 days is 10.26. The company completed stock split (1:9) on 6th of June 2019.
OpenHighLowCloseVolume
03/20/2025 8.05  8.41  8.00  8.33  1,070,583 
03/19/2025 8.95  8.95  8.03  8.26  1,260,607 
03/18/2025 8.63  8.93  7.71  8.87  1,628,628 
03/17/2025 8.60  9.04  8.50  9.00  822,458 
03/14/2025 8.18  8.72  8.18  8.60  876,916 
03/13/2025 8.44  8.61  8.10  8.11  535,770 
03/12/2025 8.25  8.59  8.13  8.52  516,170 
03/11/2025 7.96  8.28  7.65  8.20  500,959 
03/10/2025 7.96  8.20  7.70  7.95  724,109 
03/07/2025 8.07  8.21  7.82  8.01  513,059 
03/06/2025 8.01  8.19  7.91  8.15  422,308 
03/05/2025 7.51  8.20  7.51  8.16  627,897 
03/04/2025 7.34  7.69  7.22  7.58  585,483 
03/03/2025 7.84  7.93  7.31  7.40  710,872 
02/28/2025 7.98  8.13  7.77  7.85  691,626 
02/27/2025 8.32  8.52  7.99  7.99  442,631 
02/26/2025 8.25  8.37  8.13  8.27  523,567 
02/25/2025 8.46  8.63  8.24  8.25  671,615 
02/24/2025 8.33  8.74  8.13  8.50  891,253 
02/21/2025 8.90  9.14  8.20  8.33  1,044,167 
02/20/2025 9.30  9.33  8.49  8.74  1,664,256 
02/19/2025 9.80  9.94  9.20  9.30  1,054,804 
02/18/2025 10.80  11.11  9.69  9.71  1,630,273 
02/14/2025 10.70  11.07  10.58  10.68  365,803 
02/13/2025 10.43  10.64  10.00  10.63  729,617 
02/12/2025 10.03  10.35  9.94  10.26  596,073 
02/11/2025 10.04  10.36  9.76  10.32  347,399 
02/10/2025 11.13  11.46  9.98  10.27  1,004,768 
02/07/2025 12.74  12.90  11.28  11.35  641,268 
02/06/2025 12.78  12.82  12.46  12.74  701,873 
02/05/2025 12.69  12.98  12.50  12.70  1,022,066 
02/04/2025 11.52  12.85  11.30  12.60  1,375,421 
02/03/2025 11.15  11.81  11.03  11.52  1,028,992 
01/31/2025 11.07  11.73  10.92  11.48  898,881 
01/30/2025 10.66  11.15  10.55  10.99  525,797 
01/29/2025 9.80  10.85  9.76  10.51  726,098 
01/28/2025 10.50  10.60  9.72  9.82  473,422 
01/27/2025 10.53  11.11  10.36  10.57  418,501 
01/24/2025 10.59  10.85  10.48  10.62  351,177 
01/23/2025 9.90  10.67  9.66  10.60  663,567 
01/22/2025 9.77  10.43  9.66  10.02  687,130 
01/21/2025 9.47  9.82  9.30  9.80  837,640 
01/17/2025 9.55  9.65  9.35  9.36  272,475 
01/16/2025 9.59  9.59  8.98  9.46  745,990 
01/15/2025 9.04  9.77  8.81  9.49  1,405,160 
01/14/2025 9.00  9.14  8.42  8.68  916,883 
01/13/2025 8.89  9.00  8.55  8.92  1,454,008 
01/10/2025 9.00  9.11  8.77  9.00  1,612,679 
01/08/2025 9.54  9.54  8.76  8.96  1,037,383 
01/07/2025 9.82  10.56  8.88  9.31  2,308,942 
01/06/2025 11.51  11.63  10.98  11.02  528,683 
01/03/2025 11.18  11.73  11.18  11.49  682,057 
01/02/2025 11.13  11.68  10.99  11.27  403,374 
12/31/2024 10.96  11.09  10.77  11.03  206,963 
12/30/2024 10.86  11.09  10.53  10.80  510,345 
12/27/2024 11.12  11.54  10.91  11.06  324,304 
12/26/2024 11.22  11.47  11.02  11.24  439,995 
12/24/2024 11.35  11.61  11.10  11.32  517,326 
12/23/2024 11.58  11.79  11.35  11.61  2,552,306 
12/20/2024 10.81  11.84  10.81  11.68  1,183,080 
12/19/2024 11.21  11.34  10.61  11.30  769,008 

About Stoke Therapeutics Stock history

Stoke Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Stoke is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Stoke Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Stoke Therapeutics stock prices may prove useful in developing a viable investing in Stoke Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding54 M35.9 M
Net Loss-91 M-86.4 M

Stoke Therapeutics Quarterly Net Working Capital

192.7 Million

Stoke Therapeutics Stock Technical Analysis

Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Stoke Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Stoke Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Stoke Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Stoke Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Stoke Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Stoke to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Stoke Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stoke Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stoke Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Stoke Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.54)
Revenue Per Share
0.677
Quarterly Revenue Growth
7.071
Return On Assets
(0.25)
Return On Equity
(0.46)
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.